Dale Mueller, M.D.
OSF Saint Francis Medical Center
Dale Mueller, MD, is a Cardiovascular and Thoracic Surgeon at Heartcare Midwest and Vice-Chairman of the Department of Cardiovascular Medicine and Surgery at OSF Saint Francis Medical Center in Illinois. He has expertise in cardiac surgery including minimally-invasive coronary bypass, valve repair and replacement; and thoracic and aortic aneurysms, including thoracic endoprosthesis, heart transplantation and ventricular assist devices. Dr. Mueller also has experience with thoracic surgery including thoracic oncology, laser bronchoscopy, endobronchial stents, and lung volume reduction surgery. His practice also encompasses vascular surgery including endovascular repair of abdominal aortic aneurysms, lower extremity bypass, carotid endarterectomy, and percutaneous vascular interventions and angiography. Dr. Mueller’s areas of clinical research include ventricular assist devices, coronary artery bypass, thoracic oncology, endovascular surgery, and minimally invasive surgery. (This is me - Update Profile)
| 2003 - present | Vice-Chairman of Cardiovascular Medicine OSF Saint Francis Medical Center |
|---|---|
| Unspecified - present | Cardiovascular and Thoracic Surgeon Heartcare Midwest Sc |
| 1999 - 2003 | cardiovascular and thoracic surgeon Illinois Cardiac Surgery Associates |
GLG Study Groups with Dale Mueller, M.D.(?)
| Study Group Name | Members |
|---|---|
| Non-Electrophysiologist Cardiologists (US) | 851 |
| General Cardiologists (US) | 1334 |
| Physicians who Treat Hypertension (US) | 730 |
| Cardiothoracic Surgeons (US) | 332 |
GLG NewsSM Analyses by Dale Mueller, M.D.(?)
This study investigated carotid endarterectomy versus carotid stenting in patients with severe carotid stenosis. The study was stopped prematurely due to safety and futility. The 30-day incidence of stroke or death was 3.9% versus 9.6% for endarterectomy versus carotid stenting. This data implies that...
This is a general commentary regarding coronary stent thrombosis and highlights the difficulties which Medtronic (Endeavor), Abbott (Xience V and Conor Medsystem (CoStar) may soon face with FDA approval of their new stents which are currently unavailable in the US. It also highlights that drug-coated...
In a series of 15 patients, the Thoratec ventricular assist device was utilized with associated medical treatment for severe non-ischemic heart failure. Eleven of the fifteen patients recovered and avoided transplantation. Key implications include increased utilization of ventricular assist devices...
Percutaneous valves are technically feasible.Complications are currently not comparable to the traditional open valve replacement/repair.
GLG InstituteSM Seminars with Dale Mueller, M.D.(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Dale Mueller, M.D.
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.